6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
AssigneeMerck Patent GmbH
InventorsKai Schiemann, Henning Böttcher, Joachim Leibrock
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Patent GmbH
InventorsKai Schiemann, Henning Böttcher, Joachim Leibrock
Estimating the term…
Compounds of the formula I in which R1, R2, R3 and R4 are as defined in Claim 1, are ligands of the nicotinic acetylcholine receptor and/or serotonergic ligands and are suitable for the prophylaxis or treatment of psychoses, schizophrenia, depression, anxiety states, dementia, in particular Alzheimer's disease and Lewy bodies dementia, neurodegenerative disorders, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, Tourette's syndrome, learning and memory restrictions, bulimia, anorexia nervosa or other eating disorders, compulsive behavior, premenstrual syndrome, age-induced memory impairment, amelioration of withdrawal symptoms in nicotine dependence, strokes or brain damage by toxic compounds, and for the treatment of disorders which are characterized by an excess of circulating serotonin or by serotonergic hyperactivity.
A method for the treatment of psychoses, schizophrenia, depression, anxiety states, dementia, Alzheimer's disease, Lewy bodies dementia, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, Tourette's syndrome, learning and memory restrictions, bulimia, anorexia nervosa, eating disorders, compulsive behavior, premenstrual syndrome, age-induced memory impairment, strokes, brain damage by toxic compounds or amelioration of withdrawal symptoms in nicotine dependence, in which binding to nicotinic acetylcholine receptors results in an improvement in the clinical picture, comprising administering to a host in need thereof an effective amount of a compound of Formula I
Dependencies are inferred from the claim text.